Federico Mingozzi
Technik-/Wissenschafts-/F&E-Leiter bei SPARK THERAPEUTICS, INC.
Aktive Positionen von Federico Mingozzi
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SPARK THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 25.09.2017 | - |
SENSORION | Direktor/Vorstandsmitglied | 24.01.2024 | - |
Karriereverlauf von Federico Mingozzi
Ehemalige bekannte Positionen von Federico Mingozzi
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2016 | 01.09.2017 |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | Corporate Officer/Principal | 01.01.2013 | 01.09.2017 |
Ausbildung von Federico Mingozzi
University of Ferrara | Doctorate Degree |
Drexel University | Masters Business Admin |
Statistik
International
Frankreich | 4 |
Vereinigte Staaten | 3 |
Italien | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Masters Business Admin | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SENSORION | Health Technology |
Private Unternehmen | 3 |
---|---|
Spark Therapeutics, Inc.
Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Commercial Services |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | Health Technology |
- Börse
- Insiders
- Federico Mingozzi
- Erfahrung